Sign inGet started

OTLC

Oncotelic Therapeutics, Inc.CIK 908259 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
$23.5K
2 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$23.5K
Insiders on file
7

AI insights for OTLC PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for OTLC
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

$17.8K2026-10-28 buys $5.8K 2026-10-28 sales —10-282026-10-29 buys $17.8K 2026-10-29 sales —10-29
■ Open-market buys (P)   ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

InsiderRoleTradesBoughtSoldLast trade
Trieu VuongChief Executive Officer38$145.6K$02026-10-29
Fein Seymour HowardCRO/CMO1$0$02026-07-10
Saund SaranChief Business Officer6$0$02026-07-10
Shah Amit B.CHIEF FINANCIAL OFFICER4$1.0K$02026-07-10
MAIDA ANTHONY E IIIDIRECTOR AND CMO - TRANS. MED.5$0$02026-07-10
KING STEVEN WDirector5$0$02026-07-10
Diamond DavidDirector1$0$02021-07-08

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Trieu VuongCHAIRMAN AND CEO, Director, P Buy2026-10-292026-10-301,044,990$0.02 $17.8K95,481,309SEC↗
Trieu VuongCHAIRMAN AND CEO, Director, P Buy2026-10-282026-10-30312,000$0.02 $5.8K94,436,319SEC↗
Trieu VuongCHAIRMAN AND CEO A Award deriv2026-07-102026-07-142,000— $02,000SEC↗
Shah Amit B.CFO A Award deriv2026-07-102026-07-141,500— $01,500SEC↗
Saund SaranCBO A Award deriv2026-07-102026-07-141,500— $01,500SEC↗
MAIDA ANTHONY E IIIDIRECTOR AND CMO - TRANS. ME A Award deriv2026-07-102026-07-141,500— $01,500SEC↗
KING STEVEN WDirector A Award deriv2026-07-102026-07-21250— $0250SEC↗
Fein Seymour HowardCRO/CMO A Award deriv2026-07-102026-07-23250— $0250SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2026-07-012026-07-02240,000$0.04 $9.6K94,124,319SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2026-06-242026-06-24115,000$0.05 $5.8K93,884,319SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2026-06-232026-06-2475,000$0.05 $3.8K93,769,319SEC↗
Shah Amit B.CFO P Buy2026-06-222026-06-2220,000$0.05 $1.0K378,837SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2026-06-222026-06-2465,000$0.05 $3.3K93,694,319SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2026-06-172026-06-17239,759$0.04 $9.6K93,629,319SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2026-06-152026-06-1796,000$0.05 $4.8K93,389,560SEC↗
Trieu VuongCHAIRMAN AND CEO A Award deriv2026-01-222026-01-264,426— $08,491SEC↗
Trieu VuongCHAIRMAN AND CEO A Award deriv2025-11-172025-11-194,065— $04,065SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2025-07-102025-07-10104,000$0.01 $1.0K93,293,560SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2025-07-092025-07-101$0.01 $093,293,561SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2025-07-082025-07-1094,736$0.01 $94793,388,297SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2025-01-312025-01-3163,775$0.03 $1.9K93,189,560SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2025-01-302025-01-31100,003$0.03 $3.0K93,125,785SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2025-01-292025-01-31183,066$0.03 $5.5K93,025,782SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2024-11-222024-11-26298,499$0.03 $9.0K92,842,716SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2024-08-232024-08-27500,000$0.02 $10.0K92,544,217SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2023-06-292023-06-30425,000$0.02 $8.5K92,044,217SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2023-06-282023-06-3075,000$0.03 $2.3K91,619,217SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2023-06-162023-06-20100,000$0.03 $3.0K91,544,217SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2023-06-142023-06-16400,000$0.03 $12.0K91,444,217SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2023-05-262023-05-31126,888$0.03 $3.8K91,044,217SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2023-05-022023-05-02100,000$0.05 $5.0K90,917,329SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2022-12-062022-12-07120,000$0.05 $6.0K90,558,021SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2022-11-222022-11-2570,000$0.08 $5.6K90,438,021SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2022-09-262022-09-2820,000$0.07 $1.4K90,368,021SEC↗
Trieu VuongCHAIRMAN AND CEO P Buy2022-08-252022-08-2980,000$0.08 $6.4K90,348,021SEC↗
Saund SaranChief Business Officer A Award deriv2021-09-032021-09-08675,000— $0675,000SEC↗
KING STEVEN WDirector A Award deriv2021-09-032021-09-08500,000— $0500,000SEC↗
MAIDA ANTHONY E IIIChief Clin. Ops. Officer A Award deriv2021-09-032021-09-08600,000— $0600,000SEC↗
Trieu VuongChief Executive Officer A Award deriv2021-09-032021-09-08225,000— $0225,000SEC↗
Saund SaranCHIEF BUSINESS OFFICER A Award deriv2021-07-082021-07-16216,279— $0216,279SEC↗
Diamond DavidDirector A Award deriv2021-07-082021-07-16451,467— $0451,467SEC↗
Shah Amit B.CHIEF FINANCIAL OFFICER A Award deriv2021-07-082021-07-16698,256— $0698,256SEC↗
KING STEVEN WDirector A Award deriv2021-07-082021-07-16357,412— $0357,412SEC↗
Trieu VuongCHAIRMAN AND CEO A Award deriv2021-07-082021-07-16513,953— $0513,953SEC↗
MAIDA ANTHONY E IIICHIEF CLINICAL OFFICER A Award deriv2021-07-082021-07-16400,000— $0400,000SEC↗
Saund SaranCHIEF BUSINESS OFFICER A Award2021-07-082021-07-16102,519— $016,457,480SEC↗
Shah Amit B.CHIEF FINANCIAL OFFICER A Award2021-07-082021-07-16298,837— $0358,837SEC↗
Trieu VuongCHAIRMAN AND CEO A Award2021-07-082021-07-16259,302— $090,527,323SEC↗
Saund SaranCHIEF BUSINESS OFFICER C Conversion deriv2021-03-312021-07-1616,355— $00SEC↗
KING STEVEN WDirector C Conversion deriv2021-03-312021-07-163,292— $00SEC↗
Trieu VuongCHAIRMAN AND CEO C Conversion deriv2021-03-312021-07-1674,456— $00SEC↗
Trieu VuongCHAIRMAN AND CEO C Conversion deriv2021-03-312021-07-1613,849— $00SEC↗
Trieu VuongCHAIRMAN AND CEO C Conversion deriv2021-03-312021-07-165,672— $00SEC↗
MAIDA ANTHONY E IIICHIEF CLINICAL OFFICER C Conversion deriv2021-03-312021-07-16938— $00SEC↗
Saund SaranCHIEF BUSINESS OFFICER C Conversion2021-03-312021-07-1616,354,961— $016,354,961SEC↗
KING STEVEN WDirector C Conversion2021-03-312021-07-163,291,720— $03,330,647SEC↗
Trieu VuongCHAIRMAN AND CEO C Conversion2021-03-312021-07-165,672,025— $06,872,529SEC↗
Trieu VuongCHAIRMAN AND CEO C Conversion2021-03-312021-07-1613,849,161— $016,780,384SEC↗
Trieu VuongCHAIRMAN AND CEO C Conversion2021-03-312021-07-1674,455,719— $090,268,021SEC↗
MAIDA ANTHONY E IIICHIEF CLINICAL OFFICER C Conversion2021-03-312021-07-16938,646— $01,137,314SEC↗